Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like INSG: Global Nickel Surplus to Hit 198,000 MT... April 30, 2025 Stagflation Looms: Why Economists Are Warning of a... April 28, 2025 Silo Wellness Submits CSE Listing Statement for Review... September 29, 2025 Thick High-Grade Graphite Drilling Results In New Zone May 23, 2025 Alice Queen: Exploring High-grade Epithermal Gold with Near-term... August 22, 2025 Crypto Market Recap: Metaplanet Buys 1,005 Bitcoin, REX... July 1, 2025 Crypto Market Update: SEC Pauses Bitwise ETF Conversion... July 24, 2025 ICMM: These 3 Nations Control Nearly Half the... September 4, 2025 Albemarle Swings to Profit, Lowers Spending Amid Prolonged... August 2, 2025 Capital Raise Presentation August 28, 2025